1-10 of 10
epidermotropism
Close
Sort by
Journal Articles

Primary Cutaneous Small to Medium-Size CD4+ Pleomorphic T-Cell Lymphoma: 48 Patients from Two Independent Centers and Revaluation of Clinico-Histological Criteria for Differential Diagnosis from Other CTCL

Silvia Alberti-Violetti, MD, Rakhshandra Talpur, MD, Carlos Antonio Torres-Cabala, MD, Laura Corti, PhD, Emilio Berti, MD, Madeleine Duvic, MD
Journal: Blood
Blood (2014) 124 (21): 2986.
https://doi.org/10.1182/blood.V124.21.2986.2986
Published: 2014
Journal Articles

Gemcitabine in Blastic Plasmacytoid Dendritic Cell Neoplasm (CD4+CD56+ hematodermic neoplasm)

David Shepro, MD, Michael Miller, DO
Journal: Blood
Blood (2014) 124 (21): 5457.
https://doi.org/10.1182/blood.V124.21.5457.5457
Published: 2014
Journal Articles

Molecular Analysis of Primary Cutaneous Aggressive T-Cell Lymphomas: the Epidermotropic CD8+, the Pleomorphic CD8+ and the Gamma Delta Subsets.

Emilio Berti, MD, Daniele Fanoni, MS, Francesco Onida, MD, Valentina Girgenti, MD, Francesca Novara, MS, Laura Corti, MS, PhD, Luigia Venegoni, MS, Francesca Viganò€, MD, Giorgia Saporiti, MD, Orsetta Zuffardi, MD, Marco Paulli
Journal: Blood
Blood (2012) 120 (21): 2713.
https://doi.org/10.1182/blood.V120.21.2713.2713
Published: 2012
Journal Articles

A Case of ALK+ Anaplastic Large T Cell Lymphoma (ALCL) with Lymphomatous Meningitis

Bongi A. Rudder, MBBS, Nidhi Mishra, MD, Albert S. Braverman, MD, Michael Geraghty, MD, Elpidio Jimenez, MD
Journal: Blood
Blood (2011) 118 (21): 5226.
https://doi.org/10.1182/blood.V118.21.5226.5226
Published: 2011
Journal Articles

FOXP3 Can Predict Disease Progression and Risk of Transformation in Uniformly Treated Patients with Mycosis Fungoides

Nasir Bakshi, M.D., Rami Albugami, MD, Abdulmonem Almutawa, MD, Mohammed Alghamdi, Irfan Maghfoor, MD, Saad Akhter, MD
Journal: Blood
Blood (2011) 118 (21): 5182.
https://doi.org/10.1182/blood.V118.21.5182.5182
Published: 2011
Journal Articles

Clinicopathologic Characteristics and Outcome of CD4+/CD56+ Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single Institutional Experience.

Mojdeh Naghashpour, MD, PhD, I-Ting Yu, MD, Lynn C. Moscinski, MD, Lubomir Sokol, MD, PhD, Hernani Cualing, MD
Journal: Blood
Blood (2009) 114 (22): 1625.
https://doi.org/10.1182/blood.V114.22.1625.1625
Published: 2009
Journal Articles

A Soft-Drug Histone Deacetylase Inhibitor for Cutaneous T-Cell Lymphoma.

James Bradner, MD, Edward Greenberg, B.S., Sridevi Ponduru, M.D., Vishal Patel, B.S., Stuart Schreiber, Ph.D., Benjamin Rich, Ph.D., Ralph Mazitschek, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 800.
https://doi.org/10.1182/blood.V110.11.800.800
Published: 2007
Journal Articles

Design and Characterization of a Novel, Reverse Prodrug Histone Deacetylase Inhibitor for Cutaneous T-Cell Lymphoma.

James E. Bradner, MD, Edward F. Greenberg, BS, Stuart L. Schreiber, PhD, Ralph Mazitschek, PhD
Journal: Blood
Blood (2006) 108 (11): 4759.
https://doi.org/10.1182/blood.V108.11.4759.4759
Published: 2006
Journal Articles

Mycosis Fungoides, Sezary Syndrome or T-Cell Prolymphocytic Leukemia?.

Pulini Stefano, MD, Rupoli Serena, MD, Scortechini Anna Rita, MD, Tassetti Angela, MD, Goteri Gaia, MD, Bartocci Chiara, MD, Discepoli Giancarlo, MD, Mulattieri Simonetta, MD, Brunori Marino, MD, Leoni Pietro, MD
Journal: Blood
Blood (2005) 106 (11): 4673.
https://doi.org/10.1182/blood.V106.11.4673.4673
Published: 2005
Journal Articles

Successful Treatment of Cutaneous Chronic Lymphocytic Leukemia with a Topical Toll Receptor 7/8 Antagonist (Imiquimod).

Lisa Hicks, J. Mena, D. E. Spaner
Journal: Blood
Blood (2004) 104 (11): 4832.
https://doi.org/10.1182/blood.V104.11.4832.4832
Published: 2004